The EBRD said the sole investor in the bond was Dai-ichi Life. The 10-year bond had a coupon of 3.01 percent and would be listed on the regulated market of the Luxembourg Stock Exchange, EBRD added.
"Our inaugural health bond (...) will support the EBRD's key projects that seek to improve access to, and quality of, health services and pharmaceutical products in the economies where we invest," said EBRD Deputy Treasurer Isabelle Laurent.
Other multilateral organisations have also in the past sold bonds to fund health initiatives. The World Bank last year launched a "pandemic bond" aimed at funding an emergency facility.
The International Finance Facility for Immunisation has also sold bonds to raise money for vaccine programmes.